申请人:——
公开号:US20040132769A1
公开(公告)日:2004-07-08
Compounds of formula (I)
1
wherein
R is hydrogen, lower alkyl, (C
3
-C
6
)cycloalkyl, hydroxy, halo, lower alkoxy, trifluoromethoxy, trifluoromethyl or cyano; and
A is biaryl, optionally substituted &bgr;-naphthyl, bicyclic heterocyclic aryl, (C
3
-C
6
)cycloalkylmonocyclic carbocyclic aryl, or (C
5
or C
6
)cycloalkane fused-monocyclic carbocyclic aryl;
pharmaceutically acceptable salts thereof; and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
化学式为(I)1的化合物,其中R为氢、低碳基、(C3-C6)环烷基、羟基、卤素、低烷氧基、三氟甲氧基、三氟甲基或氰基;而A为双芳基、可选取代的β-萘基、双环杂环芳基、(C3-C6)环烷基单环碳环芳基,或(C5或C6)环烷基融合的单环碳环芳基;其药学上可接受的盐和酯,可用于治疗COX-2依赖性疾病。